European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Portugal — market report, September 2026

Oncology drug tenders in Portugal in September 2026: 545 tenders published (+78% month on month, +424% year on year), and 460 contracts awarded (+39% month on month, +262% year on year), worth €43,857,686 (contract value). Buyers with the most tenders: Unidade Local de Saúde de Almada-Seixal, EPE (70), Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E. (60) and Unidade Local de Saúde de Lisboa Ocidental, E. P. E. (44); most contracts won: Generis – Farmaceutica, S.A. (29), Hikma Farmacêutica (Portugal) Sa. (27) and Teva Pharma - Produtos Farmaceuticos,lda (15). On average 25.5 bids per contract; 0% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
545
Contracts awarded
460
Contract value contract
€43,857,686
Bids per contract
25.5
Tenders published per month
05001K1.5K2KSep 25: 104Sep 25: 104Sep 25Oct 25: 193Oct 25: 193Oct 25Nov 25: 328Nov 25: 328Nov 25Dec 25: 317Dec 25: 317Dec 25Jan 26: 875Jan 26: 875Jan 26Feb 26: 1,817Feb 26: 1,817Feb 26Mar 26: 394Mar 26: 394Mar 26Apr 26: 1,193Apr 26: 1,193Apr 26May 26: 1,452May 26: 1,452May 26Jun 26: 551Jun 26: 551Jun 26Jul 26: 403Jul 26: 403Jul 26Aug 26: 307Aug 26: 307Aug 26Sep 26: 545Sep 26: 545545Sep 26
Contracts awarded per month
05001K1.5KSep 25: 127Sep 25: 127Sep 25Oct 25: 194Oct 25: 194Oct 25Nov 25: 317Nov 25: 317Nov 25Dec 25: 484Dec 25: 484Dec 25Jan 26: 1,285Jan 26: 1,285Jan 26Feb 26: 1,363Feb 26: 1,363Feb 26Mar 26: 467Mar 26: 467Mar 26Apr 26: 1,432Apr 26: 1,432Apr 26May 26: 1,126May 26: 1,126May 26Jun 26: 511Jun 26: 511Jun 26Jul 26: 337Jul 26: 337Jul 26Aug 26: 330Aug 26: 330Aug 26Sep 26: 460Sep 26: 460460Sep 26

The highlighted bar is September 2026. Hover a bar for its figure; the table below has every value.

FigureSeptember 2026August 2026ChangeSeptember 2025Change
Tenders published545307+78%104+424%
Estimated value—€58,860—€4,420,864—
Buyers2526-4%10+150%
Contracts awarded460330+39%127+262%
Contract value (contract)€43,857,686€13,222,901+232%€3,841,875+1,042%
Winners5945+31%28+111%
Bids per contract25.518.4—5.1—
Single-bid contracts0%0%—55%—

Buyers with the most tenders

Companies with the most contracts

Procedures

  • not stated 544
  • Open procedure 1

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Portugal in September 2026?
545 (by 25 buyers); for comparison, August 2026: 307, September 2025: 104.
Who won the most oncology drug tenders in Portugal in September 2026?
By number of contracts: Generis – Farmaceutica, S.A. (29), Hikma Farmacêutica (Portugal) Sa. (27), Teva Pharma - Produtos Farmaceuticos,lda (15), MYLAN, Lda. (14) and Merck Sharp Dohme (13); 59 companies won contracts in all.
Which buyers published the most oncology drug tenders in September 2026?
Unidade Local de Saúde de Almada-Seixal, EPE (70), Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E. (60), Unidade Local de Saúde de Lisboa Ocidental, E. P. E. (44), Unidade Local de Saúde de Santa Maria, E. P. E. (44) and Unidade Local de Saúde do Alto Minho, EPE (ULSAM) (41).
How competitive were oncology drug tenders in Portugal in September 2026?
On average 25.5 bids per contract (210 contracts with a known number of bids); 0% of contracts had a single bid.
What were the contracts worth in September 2026?
€43,857,686 (contract value, 460 contracts); median about €5,500.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.